Related Experiment Video
Updated: Feb 11, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells
Annekathrin Reinhardt1, Hongyu Liu2, Yunxia Ma3
1Department of Neuropathology, Institute for Pathology, University of Heidelberg, Heidelberg, Germany.
Background/Aim:
One of the major problems in breast cancer treatment is pharmacoresistance. Therefore, exploration of treatment alternatives is of clinical relevance. The present work focused on tumor cell-inhibiting effects of a combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and all trans retinoic acid (ATRA) in breast cancer cells.
Materials And Methods:
Breast cancer cell lines (BT-20, BT-474, MDA-MB-231, MDA-MB-436, MDA-MB-453, MCF-7, SKBR3, T47D, ZR-75-1) and the mammary epithelial cell line MCF-10A were treated with TRAIL and ATRA alone and in combination. Cell viability was assessed via 3-(4,5)-dimethylthiahiazo(-z-yl)-3,5-di-phenytetrazoliumromide (MTT) assay, the potential of cell colony formation via clonogenic assay, cell death induction via cell-cycle analysis by fluorescence-activated cell sorting (FACS), terminal deoxynucleotidyltransferase-mediated UTP nick end labeling (TUNEL) assay and Cell death detection ELISAPLUS, expression of apoptosis and TRAIL pathway proteins via western blot and cell surface expression of TRAIL receptor 1 (DR4) via FACS analysis.
Results:
TRAIL and ATRA evoked synergistic inhibition of breast cancer cell viability based on cytostatic and cytotoxic mechanisms. This correlated with augmented fragmentation of nuclear DNA, up-regulation of TRAIL receptor, down-regulation of cyclin D1 and enhancement of caspase activity. MCF-10A cells were merely slightly susceptible to TRAIL and ATRA.
Conclusion:
The cytostatic and cytotoxic effects of the combination of TRAIL and ATRA are tumor cell-selective.
Insights
Combining tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with all-trans retinoic acid (ATRA) synergistically inhibits breast cancer cell viability. This novel combination demonstrates tumor cell-selective cytostatic and cytotoxic effects, offering a promising alternative treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Breast cancer treatment faces challenges with pharmacoresistance.
- Exploring novel therapeutic strategies is crucial for clinical relevance.
- This study investigates the combined effects of TRAIL and ATRA on breast cancer cells.
Purpose of the Study:
- To evaluate the tumor cell-inhibiting effects of combined TRAIL and ATRA.
- To assess the selectivity of this combination therapy against breast cancer cells.
- To elucidate the mechanisms underlying the synergistic effects.
Main Methods:
- Utilized multiple breast cancer cell lines and a normal mammary epithelial cell line.
- Assessed cell viability (MTT assay) and colony formation (clonogenic assay).
- Analyzed cell death (FACS, TUNEL, ELISA), protein expression (Western blot), and receptor expression (FACS).
Main Results:
- TRAIL and ATRA demonstrated synergistic inhibition of breast cancer cell viability.
- Mechanisms included cytostatic and cytotoxic effects, DNA fragmentation, and enhanced caspase activity.
- Up-regulation of TRAIL receptor and down-regulation of cyclin D1 were observed.
- Normal mammary epithelial cells showed only slight susceptibility.
Conclusions:
- The combination of TRAIL and ATRA exhibits potent cytostatic and cytotoxic effects.
- These effects are selective for tumor cells, sparing normal mammary epithelial cells.
- This combination represents a promising therapeutic approach for breast cancer treatment.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Cancer Cell Migration through Invadopodia

